Becton Dickinson Stock On Fire: Up 9.4% With 6-Day Winning Streak
Becton Dickinson (BDX) stock hit day 6 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 9.4% return. The company has gained about $4.8 Bil in value over the last 6 days, with its current market capitalization at about $55 Bil. The stock remains 13.5% below its value at the end of 2024. This compares with year-to-date returns of 14.6% for the S&P 500.
Becton Dickinson’s recent streak was underpinned by a robust Q4 EPS beat and its 54th consecutive dividend hike, reassuring investors on financial health. Further momentum stemmed from strategic innovations, notably the portable PureWick system launch for home care and enhanced Alaris EMR interoperability, signaling strong product pipeline and market expansion.
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. Our take: There is a near-equal mix of good and bad in BDX stock given its overall Moderate operating performance and financial condition. This is aligned with the stock’s Moderate valuation because of which we think it is Fairly Priced (see Buy or Sell BDX). Nevertheless, no matter where BDX stock goes, your portfolio should stay on track. See how High Quality Portfolio can help you do that.
For quick background, BDX provides medical supplies, devices, laboratory equipment, and diagnostic products for healthcare, research, and pharmaceutical industries, including IV catheters, vascular care, diabetes products, and surgical tools.
Comparing BDX Stock Returns With The S&P 500
The following table summarizes the return for BDX stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | BDX | S&P 500 |
|---|---|---|
| 1D | 0.5% | -1.7% |
| 6D (Current Streak) | 9.4% | -0.9% |
| 1M (21D) | 3.4% | 1.0% |
| 3M (63D) | -0.9% | 4.5% |
| YTD 2025 | -13.5% | 14.6% |
| 2024 | -5.4% | 23.3% |
| 2023 | -2.7% | 24.2% |
| 2022 | 5.1% | -19.4% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 62 S&P constituents with 3 days or more of consecutive gains and 40 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 27 | 28 |
| 4D | 8 | 12 |
| 5D | 15 | 0 |
| 6D | 6 | 0 |
| 7D or more | 6 | 0 |
| Total >=3 D | 62 | 40 |
Key Financials for Becton Dickinson (BDX)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $19.4 Bil | $20.2 Bil |
| Operating Income | $2.4 Bil | $2.9 Bil |
| Net Income | $1.5 Bil | $1.7 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $5.3 Bil | $5.5 Bil |
| Operating Income | $637.0 Mil | $979.0 Mil |
| Net Income | $308.0 Mil | $574.0 Mil |
While BDX stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.